preface

1
DIABETES/METABOLISM RESEARCH AND REVIEWS PREFACE Diabetes Metab Res Rev 2011; 27: 719. Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/dmrr.1301 Preface Yongsoo Park 1 Kwangwon Kim 2 Paolo Pozzilli 3,4 1 Hanyang University, Seoul, Korea 2 Sungkyunkwan University, Seoul, Korea 3 Universit` a Campus Bio-Medico di Roma, Italy 4 St Bartholomew’s & The London, Queen Mary’s School of Medicine & Dentistry, London, UK The Immunology of Diabetes Society held its 11th International Congress in Incheon, Korea, between October 31 and November 3, 2010. The proceeding of this meeting is now available to you in Diabetes/Metabolism Research and Review (as a Special Issue: Proceedings of the 11th Annual Meeting of the Immunology of Diabetes Society. This volume is a collection of the original Research Papers and Reviews discussed in this meeting, where the focus was on taking the research in autoimmune type 1 diabetes from basics to the clinical ones. The 11th IDS Congress was a unique meeting of professionals and researchers to exchange ideas and latest research, to identify and discuss the persistent issues, and to support clinical and scientific research in the field of type 1 diabetes. With the united vision of realizing a healthier world and bringing technological and scientific development to the treatment of type 1 diabetes, the Congress has been a road map to encourage health professionals in type 1 diabetes to carry out the highest quality research and to better serve patients and the global community. Previous proceedings of the IDS meetings have been published in the Annals of the New York Academy of Sciences. The IDS conducts standardization of assays for the measurement of auto-antibodies and of T cells in type 1 diabetes, part of the results of which have been introduced in the first part of this volume. This has led to considerable improvement in the sensitivity and specificity of various assay protocols, and these standards are applied and followed worldwide. The Type 1 Diabetes Genetics Consortium (T1DGC, www.t1dgc.org) is making an effort to type the entire genome with the aim of identifying the genetic loci associated with the disease. Network for pancreatic organ donors (nPOD) is a collaborative type 1 diabetes research project of sharing tissues that are rare and difficult to obtain and beneficial to the researchers. Our hope is that these collaborative approaches will prove a useful resource to the community of researchers dedicated to finding a cure for type 1 diabetes. We sincerely thank the reviewers who voluntarily participated in improving the quality of this volume and Ms. Sherry Kim and Mr. Wonsuk Choi of SUNI Comm. for helping us to put together this volume. Ms. Jungsu Lee of the Korean Diabetic Association deserves special thanks for the organizational aspects of the meeting. We would like to express our gratitude to the editorial staff at Wiley for serving the proceeding through the press. Copyright 2011 John Wiley & Sons, Ltd.

Upload: yongsoo-park

Post on 11-Jun-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Preface

DIABETES/METABOLISM RESEARCH AND REVIEWS P R E F A C EDiabetes Metab Res Rev 2011; 27: 719.Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/dmrr.1301

Preface

Yongsoo Park1

Kwangwon Kim2

Paolo Pozzilli3,4

1Hanyang University,Seoul, Korea2Sungkyunkwan University,Seoul, Korea3Universita CampusBio-Medico di Roma, Italy4St Bartholomew’s & The London,Queen Mary’s School ofMedicine & Dentistry,London, UK

The Immunology of Diabetes Society held its 11th International Congress inIncheon, Korea, between October 31 and November 3, 2010. The proceedingof this meeting is now available to you in Diabetes/Metabolism Research andReview (as a Special Issue: Proceedings of the 11th Annual Meeting of theImmunology of Diabetes Society. This volume is a collection of the originalResearch Papers and Reviews discussed in this meeting, where the focus wason taking the research in autoimmune type 1 diabetes from basics to theclinical ones.

The 11th IDS Congress was a unique meeting of professionals andresearchers to exchange ideas and latest research, to identify and discussthe persistent issues, and to support clinical and scientific research in thefield of type 1 diabetes. With the united vision of realizing a healthier worldand bringing technological and scientific development to the treatment oftype 1 diabetes, the Congress has been a road map to encourage healthprofessionals in type 1 diabetes to carry out the highest quality research andto better serve patients and the global community.

Previous proceedings of the IDS meetings have been published inthe Annals of the New York Academy of Sciences. The IDS conductsstandardization of assays for the measurement of auto-antibodies and ofT cells in type 1 diabetes, part of the results of which have been introduced inthe first part of this volume. This has led to considerable improvement in thesensitivity and specificity of various assay protocols, and these standards areapplied and followed worldwide. The Type 1 Diabetes Genetics Consortium(T1DGC, www.t1dgc.org) is making an effort to type the entire genome withthe aim of identifying the genetic loci associated with the disease. Network forpancreatic organ donors (nPOD) is a collaborative type 1 diabetes researchproject of sharing tissues that are rare and difficult to obtain and beneficial tothe researchers. Our hope is that these collaborative approaches will prove auseful resource to the community of researchers dedicated to finding a curefor type 1 diabetes.

We sincerely thank the reviewers who voluntarily participated in improvingthe quality of this volume and Ms. Sherry Kim and Mr. Wonsuk Choi of SUNIComm. for helping us to put together this volume. Ms. Jungsu Lee of theKorean Diabetic Association deserves special thanks for the organizationalaspects of the meeting. We would like to express our gratitude to the editorialstaff at Wiley for serving the proceeding through the press.

Copyright 2011 John Wiley & Sons, Ltd.